By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market on Wednesday that its first-quarter revenues slid 8 percent, but the company recorded a modest profit.

For the three months ended March 31, the Santa Clara, Calif.-based microarray company recorded revenues of $73.7 million, down from $80.2 million a year ago and missing analyst estimates of $75.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.